Tesamorelin For Sale — Research Grade
PX1 Research provides laboratory-grade Tesamorelin synthesized under strict quality controls for academic and institutional research applications. Every lot undergoes rigorous third-party analytical verification to ensure exceptional chemical purity, sequence identity, and minimal endotoxin levels. Qualified investigators sourcing Tesamorelin can rely on our transparent testing standards, ISO 17025 lab reports, and same-day dispatch from our USA facilities.
Quick answer
PX1 Research provides laboratory-grade Tesamorelin synthesized under strict quality controls for academic and institutional research applications. Every lot undergoes rigorous third-party analytical verification to ensure exceptional chemical purity, sequence identity, and minimal endotoxin levels. Qualified investigators sourcing Tesamorelin can rely on our transparent testing standards, ISO 17025 lab reports, and same-day dispatch from our USA facilities.
Key takeaways
- [Tesamorelin](/research-peptides/tesamorelin) is a synthetic peptide derivative of human growth hormone-releasing hormone (GHRH) consisting of 44 amino acids.
- At the structural level, [Tesamorelin](/research-peptides/tesamorelin) comprises the 44-amino-acid sequence of endogenous human GHRH stabilized by a hexenoyl group attached to its N-terminal tyrosine residue (trans-3-hexenoic acid addition).
- Preclinical investigation into [GHRH analogs](/research-peptides/ghrh-analogs) centers primarily on endocrine signaling cascades within the somatotropic axis.
- A major area of study for [Tesamorelin](/research-peptides/tesamorelin) involves metabolic pathways, specifically visceral adiposity and hepatic lipid accumulation.
High-Purity Tesamorelin for Advanced Laboratory Research
Tesamorelin is a synthetic peptide derivative of human growth hormone-releasing hormone (GHRH) consisting of 44 amino acids. When principal investigators search for tesamorelin for sale, chemical purity and structural integrity are paramount to achieving reproducible experimental results. PX1 Research delivers research-grade Tesamorelin specifically engineered for rigorous in vitro assays and preclinical animal models.
As a specialized supplier of research peptides, PX1 Research subjects every lot of Tesamorelin to comprehensive analytical screening. Synthesis takes place in state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) protocols, ensuring that non-target peptide fragments, residual solvents, and counterions are systematically removed during purification.
Molecular Structure and Mechanism as a GHRH Analog
At the structural level, Tesamorelin comprises the 44-amino-acid sequence of endogenous human GHRH stabilized by a hexenoyl group attached to its N-terminal tyrosine residue (trans-3-hexenoic acid addition). This structural modification alters the peptide's enzyme cleavage kinetics, rendering it significantly more resistant to dipeptidyl peptidase-4 (DPP-IV) degradation compared to native GHRH(1-44) amide.
In cell culture models and isolated pituitary slice preparations, Tesamorelin binds selective GHRH receptors on anterior pituitary somatotrophs. Receptor activation stimulates the adenylate cyclase/cAMP/protein kinase A (PKA) signal transduction cascade, inducing intracellular calcium influx and triggering the pulsatile exocytosis of endogenous growth hormone (GH). Research indicates this physiological stimulation preserves intact feedback loops, contrasting with direct recombinant GH administration.
Primary Research Pathways: GH/IGF-1 Axis Regulation
Preclinical investigation into GHRH analogs centers primarily on endocrine signaling cascades within the somatotropic axis. Elevated somatotroph exocytosis leads to downstream hepatic transcription and secretion of insulin-like growth factor 1 (IGF-1). Researchers monitor these circulating biomarker shifts to assess target engagement and receptor responsiveness.
In vitro data indicate that Tesamorelin-mediated GHRH receptor signaling does not disrupt basal somatostatin regulation. This preserves natural GH pulse amplitudes and baseline clearance kinetics. Consequently, investigators utilize Tesamorelin in cell culture systems and rodent models to evaluate the transcriptional regulation of IGF-binding proteins (IGFBPs) and downstream tissue-specific cell proliferation pathways.
Preclinical Investigation of Metabolic Regulation and Visceral Adiposity
A major area of study for Tesamorelin involves metabolic pathways, specifically visceral adiposity and hepatic lipid accumulation. Rodent and non-human primate models demonstrate that sustained activation of the GH/IGF-1 axis upregulates lipolysis in visceral adipocytes through hormone-sensitive lipase (HSL) phosphorylation and beta-adrenergic receptor upregulation.
Preclinical studies suggest that Tesamorelin administration in metabolic models leads to reduced intra-abdominal fat volume, improved hepatic insulin sensitivity, and decreased triglyceride storage within hepatocytes. Researchers frequently incorporate Tesamorelin into studies examining metabolic syndrome, lipodystrophy models, and non-alcoholic fatty liver disease (NAFLD) cellular pathways to quantify shifts in lipid flux and inflammatory cytokines.
Examining Tissue Repair, Neurological, and Cardiovascular Preclinical Models
Beyond visceral fat regulation, Tesamorelin is actively studied for its broad tissue-repair and neuroprotective capabilities. GH and IGF-1 signaling cascades play critical roles in extracellular matrix deposition, protein translation in skeletal muscle tissue, and microvascular endothelial repair following ischemic injury.
In vitro assays using neuronal cell cultures demonstrate that GHRH receptor activation by Tesamorelin exerts neuroprotective effects against oxidative stress and amyloid-beta-induced apoptosis. Furthermore, rodent models of nerve injury suggest that Tesamorelin-stimulated systemic IGF-1 production accelerates peripheral nerve regeneration and functional recovery, providing an exciting foundation for ongoing regenerative medicine research.
Comparative Analysis: Tesamorelin vs. CJC-1295, Sermorelin, and Ipamorelin
When designing comparative secretagogue protocols, researchers must evaluate structural differences and receptor affinities across the GHRH and GHRP classes. While Tesamorelin is a stabilized 44-amino-acid GHRH analog targeting visceral fat pathways, CJC-1295 represents a modified 29-amino-acid GHRH variant optimized for altered plasma half-life. In contrast, short-chain analogs like Sermorelin incorporate only the terminal 29-amino-acid sequence of GHRH, yielding a faster enzymatic clearance profile in rodent models.
To achieve synergistic growth hormone release, investigators often evaluate GHRH receptor agonists alongside growth hormone secretagogue receptor (GHSR-1a) ligands. For instance, pairing a GHRH analog with Ipamorelin or GHRP-2 in vitro demonstrates dual-receptor activation, producing a amplified GH release pulse without triggering elevated cortisol or prolactin secretion. Detailed protocol comparisons can be explored within our comprehensive research library.
Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Testing
To guarantee valid and reproducible scientific outcomes, PX1 Research subjects every batch of Tesamorelin to rigorous analytical evaluation by an independent ISO 17025 accredited laboratory. Standard testing protocols verify purity, batch-to-batch consistency, and exact molecular mass.
High-Performance Liquid Chromatography (HPLC) profiles confirm liquid chemical purity of ≥98%, while Mass Spectrometry (MS) verifies exact molecular weight and amino acid sequence identity. Furthermore, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below <0.01 EU/µg. Lot-specific Certificates of Analysis (COA) are publicly accessible for full research compliance.
Laboratory Handling, Storage, and Reconstitution Guidelines
Tesamorelin is supplied as a lyophilized (freeze-dried) powder sealed under inert gas to maintain long-term peptide stability. Upon receipt, unopened vials should be stored in a commercial freezer at -20°C or -80°C to prevent hydrolysis and peptide degradation. Under these conditions, the lyophilized cake remains stable for up to 24 months.
For laboratory reconstitution, researchers should allow the vial to reach room temperature before introducing sterile bacteriostatic water or normal saline solution. Reconstitute by directing the diluent down the glass vial wall, followed by gentle swirling—never vigorous shaking—to prevent mechanical shear stress on the peptide chain. Reconstituted solutions should be aliquoted and stored at 2°C to 8°C, maintained under sterile conditions, and used within experimental trial timelines.
Sourcing Research-Grade Tesamorelin: Order Fulfillment and Supply Chain Integrity
Maintaining supply chain speed and product stability is vital for active academic, biotechnological, and institutional laboratories. PX1 Research operates centralized fulfillment centers located in California and Arizona, allowing us to process and dispatch all verified orders on the same day when placed Monday through Friday before cut-off times.
All shipments are packaged in temperature-controlled, impact-resistant materials to ensure chemical stability during transit. Institutional buyers and lab managers seeking high-volume orders or custom analytical packaging can establish a dedicated bulk research account to streamline procurement, secure priority batch allocation, and access wholesale pricing tiers.
Frequently Asked Questions
What is the primary mechanism of action of Tesamorelin in research models?
Tesamorelin acts as a synthetic growth hormone-releasing hormone (GHRH) analog that selectively binds GHRH receptors on anterior pituitary somatotrophs, stimulating cyclic AMP signaling to induce pulsatile secretion of endogenous growth hormone and elevate downstream hepatic IGF-1 expression.
How is Tesamorelin verified for purity and identity at PX1 Research?
Every lot of Tesamorelin undergoes third-party ISO 17025 laboratory testing. Analytical verification includes High-Performance Liquid Chromatography (HPLC) for ≥98% purity, Mass Spectrometry (MS) for sequence mass verification, and LAL assays to confirm minimal endotoxin content (<0.01 EU/µg).
What structural modification distinguishes Tesamorelin from native GHRH(1-44)?
Tesamorelin features a hexenoyl group attached to its N-terminal tyrosine residue (trans-3-hexenoic acid modification). This chemical modification increases resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-IV), enhancing plasma stability compared to native GHRH.
How fast does PX1 Research ship Tesamorelin orders?
PX1 Research dispatches orders same-day Monday through Friday from our fulfillment centers in California and Arizona, provided the order is finalized before daily cut-off times.
What solvent should be used to reconstitute Tesamorelin for in vitro assays?
Tesamorelin is typically reconstituted using sterile bacteriostatic water or standard laboratory grade phosphate-buffered saline (PBS), depending on the specific cell culture or assay buffer requirements.
What are the recommended storage temperature parameters for lyophilized Tesamorelin?
Lyophilized Tesamorelin should be stored at -20°C or -80°C for long-term storage (up to 24 months). Reconstituted solutions should be kept refrigerated between 2°C and 8°C and evaluated within short experimental timeframes.
Can academic labs order Tesamorelin in bulk quantities?
Yes, verified academic laboratories, biotechnology institutions, and commercial researchers can apply for a wholesale research account to access bulk tier pricing and dedicated batch reservations.
Is Tesamorelin approved for human consumption or therapeutic administration?
No. Products supplied by PX1 Research, including Tesamorelin, are strictly intended for in vitro assays, laboratory analysis, and preclinical research applications. They are strictly not for human or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.